The treatment of patients

November 30th, 2009 by admin

The average person prolonged life by about 2.5 months but some men gained several years, according to studies. Taxotere, when used with prednisone, is the first chemotherapy drug therapy proven to help some patients with advanced prostate cancer live longer. Patients may also experience neuropathy and fluid retention. Side effects of Taxotere are similar to most chemotherapy drugs and include nausea, possible hair loss, and bone marrow suppression. Patients receive Taxotere, along with prednisone, through an injection. Taxotere works by preventing prostate health cancer cells from dividing and growing. In 2004, the FDA approved the chemotherapy drug Taxotere, taken with prednisone, for the treatment of patients who no longer respond to hormone therapy. Indication Uroxatral is an alpha1-blocker for the treatment of patients who no longer respond to hormone therapy have another option. Doctors call this hormone refractory prostate cancer. Eventually most patients with advanced prostate cancer stop responding to hormone therapy.